GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » Beta

Sinohealth Holdings (HKSE:02361) Beta : N/A (As of Apr. 06, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-04-06), Sinohealth Holdings's Beta is Not available.


Sinohealth Holdings Beta Historical Data

The historical data trend for Sinohealth Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings Beta Chart

Sinohealth Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beta
- - - - -

Sinohealth Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beta Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Sinohealth Holdings's Beta

For the Health Information Services subindustry, Sinohealth Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinohealth Holdings's Beta Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sinohealth Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Sinohealth Holdings's Beta falls into.


;
;

Sinohealth Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Sinohealth Holdings  (HKSE:02361) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sinohealth Holdings Beta Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinohealth Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Executives
Futu Trustee Limited 2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd 2201 Interest of corporation controlled by you
Yu Rong 2201 Interest of corporation controlled by you
Tianyi (bvi) Limited 2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang 2201 Interest of corporation controlled by you
Wu Yushu 2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited 2101 Beneficial owner
Li Hanxiong 2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd 2101 Beneficial owner
Wu Meirong 2202 Interest of your spouse
Ying Lian You Xian Gong Si 2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines